Department of Brain Sciences, Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK.
School of Psychology, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Int J Environ Res Public Health. 2021 Dec 14;18(24):13161. doi: 10.3390/ijerph182413161.
People with intellectual disabilities (PwID) are at a higher risk of developing challenging behaviours (CB). Despite the poor evidence for the effectiveness of medications in managing CB, they are used widely among PwID (50-63%). The aims of our study were to develop a training programme, SPECTROM for support staff to help reduce overmedication in PwID and carry out field testing of SPECTROM including a process evaluation. We developed SPECTROM using the Experience-based co-design method that included four focus groups and a one-day co-design event. Twenty trainees received SPECTROM training. We used the Management of Aggression and Violence Attitudes Scale-Revised-Intellectual Disabilities (MAVAS-R-ID) and the Psychotropic knowledge questionnaire. A semi-structured interview and a feasibility questionnaire were used for process evaluation. SPECTROM website contains 14 modules, resources, and face-to-face training. MAVAS-R-ID scores showed change in staff attitude to 'medication management' domain was statistically significant ( < 0.05). Psychotropic knowledge questionnaire showed statistically significant post-training improvement in correct responses ( < 0.05). Process evaluation data showed that SPECTROM was acceptable, applicable, practical, and relevant to staff practice, and helped to improve self-reflection, knowledge, and support to PwID. SPECTROM is a useful training that helps to change the support staff's attitude toward CB and improve their knowledge of psychotropic medications.
智障人士(PwID)患挑战性行为(CB)的风险较高。尽管药物在管理 CB 方面的有效性证据不足,但它们在 PwID 中广泛使用(50-63%)。我们的研究目的是开发一种培训计划,即 SPECTROM,供支持人员使用,以帮助减少 PwID 的过度用药,并对 SPECTROM 进行现场测试,包括进行过程评估。我们使用基于经验的共同设计方法开发了 SPECTROM,其中包括四个焦点小组和一天的共同设计活动。二十名学员接受了 SPECTROM 培训。我们使用了攻击性和暴力态度量表修订版 - 智力障碍版(MAVAS-R-ID)和精神药物知识问卷。半结构化访谈和可行性问卷用于过程评估。SPECTROM 网站包含 14 个模块、资源和面对面培训。MAVAS-R-ID 评分显示员工对“药物管理”领域的态度变化具有统计学意义(<0.05)。精神药物知识问卷显示正确回答的培训后改善具有统计学意义(<0.05)。过程评估数据表明,SPECTROM 是可以接受的、适用的、实用的,与员工的实践相关,并有助于提高自我反思、知识和对 PwID 的支持。SPECTROM 是一种有用的培训,可以帮助改变支持人员对 CB 的态度,并提高他们对精神药物的知识。